What is the recommended dosereckoned dose of Co-amoxiclav (amoxicillin/clavulanic acid) Natravox 312.5mg per 5mL Powder for Suspension for a 5-year-old child weighing 21 kilograms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-amoxiclav Dosing for a 5-Year-Old Child Weighing 21 kg

For a 5-year-old child weighing 21 kg, the recommended dose is 5 mL of the 125/31 suspension three times daily, providing approximately 125 mg of amoxicillin per dose (375 mg total daily). 1

However, this standard dosing provides only approximately 18 mg/kg/day of amoxicillin, which is substantially below the recommended therapeutic doses for most bacterial infections requiring co-amoxiclav. 1

Critical Dosing Considerations

Standard vs. High-Dose Regimens

The appropriate dose depends entirely on the indication and risk factors:

For most respiratory tract infections and β-lactamase producing organisms:

  • The American Academy of Pediatrics recommends 45 mg/kg/day in 3 doses OR 90 mg/kg/day in 2 doses of the amoxicillin component 1, 2
  • For a 21 kg child, this translates to either:
    • 315 mg three times daily (945 mg/day total), OR
    • 945 mg twice daily (1890 mg/day total) 1

High-dose regimen (90 mg/kg/day) is specifically indicated for: 1

  • Children <2 years of age
  • Daycare attendance
  • Recent antibiotic use (within 30 days)
  • Incomplete Haemophilus influenzae type b vaccination
  • Geographic areas with high pneumococcal resistance (>10%)
  • Moderate to severe illness
  • Concurrent purulent acute otitis media

Practical Dosing with Available Suspension

The 312.5 mg/5 mL suspension (125 mg amoxicillin/31.25 mg clavulanate per 5 mL) is NOT the appropriate formulation for achieving recommended therapeutic doses in a 21 kg child. 1

To achieve proper dosing:

  • For 45 mg/kg/day regimen: Would require approximately 7.5 mL three times daily of the 125/31 suspension 1
  • For 90 mg/kg/day regimen: Would require approximately 15 mL twice daily of the 125/31 suspension, OR preferably use the 250/62 suspension at 7.5 mL twice daily 1

Common Pitfalls to Avoid

Critical dosing errors occur when: 1

  • Using age-based dosing instead of weight-based dosing for serious infections
  • Failing to verify the suspension concentration before calculating volume
  • Using subtherapeutic doses, which leads to treatment failure and promotes antimicrobial resistance
  • Not considering risk factors that mandate high-dose therapy

The American Academy of Pediatrics explicitly warns that subtherapeutic doses fail to achieve adequate serum and tissue concentrations to overcome even susceptible organisms, and treatment failure with resistant organisms is inevitable when standard doses are not used. 1

Treatment Duration and Monitoring

  • Standard treatment duration is 7-10 days for most infections, with 10 days specifically recommended for pneumonia and acute otitis media 1, 2
  • Children should demonstrate clinical improvement within 48-72 hours 3
  • If no improvement or worsening occurs after 72 hours, reevaluation and consideration of switching antibiotics or further investigation is necessary 1

Most Common Adverse Effects

  • Diarrhea, nausea, vomiting, and rash are the most common adverse effects 1
  • The 14:1 ratio formulation (90/6.4 mg/kg/day) causes less diarrhea than other amoxicillin-clavulanate preparations while maintaining efficacy 1

References

Guideline

Amoxicillin-Clavulanate Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amoxicillin Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amoxicillin-Clavulanate Dosing Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is co-amoxiclav (amoxicillin/clavulanic acid) 228.5/5 mg an appropriate dose for a 7-year-old patient?
What is the correct oral dosage computation of co-amoxiclav (amoxicillin-clavulanate) for a pediatric patient with impaired renal function and a history of allergic reactions to penicillins?
What is the recommended dose of Augmentin (amoxicillin-clavulanate) for a 30kg child?
What is the appropriate dosage of Co-amoxiclav (amoxicillin/clavulanic acid) 250mg/65mg per 7.5mL for a 41kg, 8-12 year old child?
What is the recommended dosage of Co-amoxiclav (amoxicillin/clavulanic acid) for pediatric patients?
What is the recommended treatment approach for patients with intermediate or advanced hepatocellular carcinoma (HCC) using Transarterial Chemoembolization (TACE) plus Lenvatinib (levatinib)?
What are the guidelines for using antihistamines, such as diphenhydramine (Benadryl) or loratadine (Claritin), in pediatric patients with allergic reactions or conditions like atopic dermatitis, considering age, weight, and medical history?
Can Pneumococcal Conjugate Vaccine 20 (PCV20) be administered to a healthy infant at 6 weeks, 10 weeks, and 14 weeks of age?
What is the cause and management of bradycardia in a patient with increased intracranial pressure (ICP)?
Can I give Pneumococcal Conjugate Vaccine 20 (PCV20) as the 4th dose to a healthy child between 1 to 2 years old who has already received the first three doses of a pneumococcal conjugate vaccine?
For a patient with intermediate or advanced hepatocellular carcinoma (HCC), which treatment should be started first, Transarterial Chemoembolization (TACE) or Lenvatinib (Lenvatinib)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.